The RNA-binding protein HuR stabilizes survivin mRNA in human oesophageal epithelial cells

被引:29
作者
Donahue, James M. [1 ,2 ]
Chang, Elizabeth T. [1 ,2 ]
Xiao, Lan [1 ,2 ]
Wang, Peng-Yuan [1 ,2 ]
Rao, Jaladanki N. [1 ,2 ]
Turner, Douglas J. [1 ,2 ]
Wang, Jian-Ying [1 ,2 ,3 ]
Battafarano, Richard J. [1 ]
机构
[1] Univ Maryland, Sch Med, Cell Biol Grp, Dept Surg, Baltimore, MD 21201 USA
[2] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
Hu antigen R (HuR); mRNA stability; p53; ribonucleoprotein; survivin; 3 '-untranslated region (3 '-UTR); KINASE-REGULATED PHOSPHORYLATION; WILD-TYPE P53; APOPTOSIS PROTEIN; LUNG-CANCER; EXPRESSION; INHIBITION; POLYAMINES; COMPLEX; IMPORTIN-ALPHA-1; PROLIFERATION;
D O I
10.1042/BJ20110028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Overexpression of survivin, a member of the IAP (inhibitor of apoptosis) family, has been correlated with poorer outcomes in multiple malignancies, including oesophageal cancer. The regulatory mechanisms, particularly at the post-transcriptional level, involved in survivin overexpression are not well understood. Previous work from our group has shown that the RNA-binding protein HuR (Hu antigen R), which is also overexpressed in several malignancies, stabilizes the mRNA of XIAP (X-linked IAP), another IAP family member. In the present study, we demonstrate the binding of HuR to a 288 bp fragment in the 3'-UTR (untranslated region) of survivin mRNA in human oesophageal epithelial cells. Unexpectedly, overexpression of HuR led to a decrease in survivin expression. This was associated with decreased survivin mRNA and promoter activity, suggesting a decrease in transcription. Levels of p53, a negative transcriptional regulator of survivin, increased following HuR overexpression, in conjunction with enhanced p53 mRNA stability. Silencing p53 prior to HuR overexpression resulted in increased survivin protein and mRNA stability. These results demonstrate that, in the absence of p53, HuR overexpression results in increased survivin mRNA stability and protein expression. This provides an additional explanation for the increased survivin expression observed in oesophageal cancer cells that have lost p53.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 40 条
[1]   Posttranscriptional orchestration of an anti-apoptotic program by HuR [J].
Abdelmohsen, Kotb ;
Lal, Ashish ;
Kim, Hyeon Ho ;
Gorospe, Myriam .
CELL CYCLE, 2007, 6 (11) :1288-1292
[2]   Survivin, versatile modulation of cell division and apoptosis in cancer [J].
Altieri, DC .
ONCOGENE, 2003, 22 (53) :8581-8589
[3]   Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma [J].
Aoki, Y ;
Feldman, GM ;
Tosato, G .
BLOOD, 2003, 101 (04) :1535-1542
[4]   Post-transcriptional regulation in cancer [J].
Audic, Y ;
Hartley, RS .
BIOLOGY OF THE CELL, 2004, 96 (07) :479-498
[5]  
Blaxall BC, 2000, MOL CARCINOGEN, V28, P76
[6]   HuR and mRNA stability [J].
Brennan, CM ;
Steitz, JA .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (02) :266-277
[7]   Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line [J].
Chang, Elizabeth ;
Donahue, James ;
Smith, Anna ;
Hornick, John ;
Rao, Jaladanki N. ;
Wang, Jian-Ying ;
Battafarano, Richard J. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (01) :225-232
[8]   DETECTION OF THE ANTI-HU ANTIBODY IN THE SERUM OF PATIENTS WITH SMALL-CELL LUNG-CANCER - A QUANTITATIVE WESTERN-BLOT-ANALYSIS [J].
DALMAU, J ;
FURNEAUX, HM ;
GRALLA, RJ ;
KRIS, MG ;
POSNER, JB .
ANNALS OF NEUROLOGY, 1990, 27 (05) :544-552
[9]   Role of the RNA-binding protein HuR in colon carcinogenesis [J].
de Silanes, IL ;
Fan, JS ;
Yang, XL ;
Zonderman, AB ;
Potapova, O ;
Pizer, ES ;
Gorospe, M .
ONCOGENE, 2003, 22 (46) :7146-7154
[10]   Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma [J].
Denkert, C ;
Weichert, W ;
Winzer, KJ ;
Müller, BM ;
Noske, A ;
Niesporek, S ;
Kristiansen, G ;
Guski, H ;
Dietel, M ;
Hauptmann, S .
CLINICAL CANCER RESEARCH, 2004, 10 (16) :5580-5586